Hong, Soon Jun <br/><br/>
A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled Trial.  [electronic resource] 

 -  Clinical therapeutics  02 2018 
 - 226-241.e4 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1879-114X 
<br/><br/><label>Standard No.: </label>10.1016/j.clinthera.2017.12.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anticholesteremic Agents--administration & dosage<br/>Cholesterol, LDL--blood<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Ezetimibe--administration & dosage<br/>Female<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--administration & dosage<br/>Hypercholesterolemia--drug therapy<br/>Male<br/>Middle Aged<br/>Republic of Korea<br/>Rosuvastatin Calcium--administration & dosage<br/>Treatment Outcome